n=119 | |
Age, mean (SD) years | 65.0 (10.1) |
Post-menopausal | n (%) |
Yes | 107 (89.9) |
No | 12 (10.1) |
WHO performance status | n (%) |
0 | 90 (75.6) |
1 | 22 (18.5) |
2 | 6 (5.0) |
3 | 0 (0.0) |
4 | 0 (0.0) |
NA | 1 (0.9) |
Stage | n (%) |
1 | 12 (10.1) |
2 | 18 (15.1) |
3 | 75 (63.1) |
4 | 11 (9.2) |
NA | 3 (2.5) |
Extent | n (%) |
Low | 43 (36.1) |
Moderate | 34 (28.6) |
High | 32 (26.9) |
NA | 10 (8.4) |
Management decision | n (%) |
Primary debulking surgery | 78 (65.5) |
Interval debulking surgery | 36 (30.3) |
No surgery | 5 (4.2) |
Cytoreduction rate | n (%) |
Complete | 73 (61.3) |
Residual <1 cm | 18 (15.1) |
Residual ≥1 cm | 2 (1.7) |
Inoperable | 9 (7.6) |
NA | 17 (14.3) |
FIGO stage 1 C3 and above | n=110 |
Received chemotherapy | n (%) |
No | 16 (14.5) |
Yes | 92 (83.7) |
NA | 2 (1.8) |
FIGO, International Federation of Gynecology and Obstetrics; NA, not available.